BioTrinity is OBN's flagship two-day conference for the life sciences industry, designed to catalyse growth for all who attend. The delegate mix comprises early stage and emerging life sciences R&D companies, investors, big pharma, academics, charities, government, and broad range of valued service providers.
After the sell-out success of BioTrinity 2023, OBN are pleased to announce the 2024 edition will be hosted in a larger capacity venue, etc. venues 133 Houndsditch in London. The move will allow us to deliver an enhanced format, in a more spacious environment, whilst ensuring we continue to catalyse success for all who attend.
Key changes for 2024 include:
An increase in audience size of c.15%
More spacious partnering area
Three tracks of presentations; two science focused and one business/investment focused, with each track incorporating more breaks and added time for questions with speakers
Plenty of informal seating space for delegates to catch up on calls and take impromptu meetings
An all-delegate networking party on-site at the conference venue on Tuesday 23 April, included in the delegate ticket price
Additional conference features include:
Scientific spotlight presentations from Series A stage companies across Oncology, Neuroscience, Microbiome, Inflammatory Diseases, Rare Diseases, Infectious Diseases, Medtech, AI & Drug Discovery, Ageing, Cell & Gene Therapy and more
Two days of pre-scheduled in-person private partnering meetings and a bonus virtual third day
An enhanced sponsors exhibition
Two-days of catering for all delegates, including the new all-delegate networking evening on Tuesday 23 April
Access to digital content from the business track, and presentations from the scientific sessions
*We are pleased to confirm that delegates rates remain unchanged for 2024*